Atlas Trials

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081

Clinical trial NCT04608955 · COMPLETED

Trial details

NCT number
NCT04608955
Sponsor
Shanghai Jiatan Pharmatech Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Tuberculosis
Start date
2020-10-16
Primary completion
2022-04-13
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.